Subnavigation

• Genomics home
• Health professionals
• Policy makers
• Patients and public
• Ethical, legal and social implications
• Research
• Craniofacial anomalies

Noncommunicable diseases

Cancer

• Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.
  Lim BC, Ariens RA, Carter AM, Weisel JW, Grant PJ.
  Lancet 2003 Apr 26; 361(9367): 1424-31
• MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks.
  Villemure JF, Abaji C, Cousineau I, Belmaaza A.
  Cancer Research 2003 Jun 15; 63(12): 3334-9
• Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer
  Marc Tischkowitz, Ros Eeles and IMPACT collaborators (IMPACT study: Identification of Men with genetic predisposition to Prostate Cancer and its Clinical Treatment)
  Lancet 2003 July; 362 (9377): 80.
• The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription.
  Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, Brimmell M, Mullee MA, Johnson PW, Royle GT, Bateman AC, Packham G.
  Oncogene 2003 Aug 7; 22(32): 4973-4982.
• Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation.
  Harvey AJ, Crompton MR.
  Oncogene 2003 Aug 7; 22(32): 5006-10.
• Genetic susceptibility and dietary patterns in lung cancer
  Ya-Yu Tsai, Katherine A. McGlynn, Ying Hua, Anna B. Cassidy, John Arnold, Paul F. Engstrom and Kenneth H Buetow
  Lung Cancer 2003 September, Vol 41, Issue 3, 269-281
• A Census of Human Cancer Genes
  P. Andrew Futreal, Lachlan Coin, Mhairi Marshall, Thomas Down, Timothy Hubbard, Richard Wooster, Nazneen Rahman & Michael R. Stratton
  Nature Reviews Cancer 2004, 4, 177-183
• Genetic Testing for Cancer Susceptibility: the Promise and the Pitfalls
  Caryn Lerman & Alexandra E. Shields
  Nature Reviews Cancer 2004, 4, 235 -241
• Predictive genetics in primary care: expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk.
  Laud K, Kannengiesser C, Avril MF, Chompret A, Stoppa-Lyonnet D, Desjardins L, Eychene A, Demenais F, Lenoir GM, Bressac-de Paillerets B; French Herediatary Melanoma Study Group
  Cancer Research 2003 Jun 15; 63(12): 3061-5.
• Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes
  I A McNeish, S J Bell and N R Lemoine
  Gene Therapy 2004 March, Vol. 11, No. 6, 497-503
• Guidelines for the management of women at increased familial risk of breast cancer
  P Sauven
  European Journal of Cancer 2004 March;Vol 40; Issue 5, 653-665
• Colorectal cancer screening in Europe: first things first
  J. W. W. Coebergh
  European Journal of Cancer 2004 March; Vol. 40; Issue 5, 638-642
• Family history of benign thyroid disease and cancer and risk of thyroid cancer
  A. Memon, A. Berrington de González, Y. Luqmani and A. Suresh
  European Journal of Cancer 2004 March, Vol 40; Issue 5, 754-760
• Do Physicians Tailor Their Recommendations for Breast Cancer Risk Reduction Based on Patient's Risk?
  Jennifer S. Haas, Celia P. Kaplan, Steven E. Gregorich, Eliseo J. Perez-Stable, Genevieve Des Jarlais
  Journal of General Internal Medicine 2004; Vol 19, Issue 4: 302.
• Obesity and Breast Cancer Screening. The Influence of Race, Illness
  Christina C. Wee, Ellen P. McCarthy, Roger B. Davis, Russell S. Phillips
  Journal of General Internal Medicine 2004; Vol 19, Issue 4: 324
• Tracing the network connecting BRCA and Fanconi Anaemia proteins
  Ashok R. Venkitaraman
  Nature Reviews Cancer 2004; 4: 266-276
• CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer
  Zhongmin Guo, Jörgen F. Linn, Guojun Wu, Sarah L Anzick, Claus F Eisenberger, Sarel Halachmi, Yoram Cohen, Alexey Fomenkov, Mohammad Obaidul Hoque, Kenji Okami, Gabriel Steiner, James M Engles, Motonabu Osada, Chulso Moon, Edward Ratovitski, Jeffrey M Trent, Paul S Meltzer, William H Westra, Lambertus A Kiemeney, Mark P Schoenberg, David Sidransky & Barry Trink
  Nature Medicine 2004 April, 10, 374–381
• Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study
  Rose PW, Murphy M, Munafo M, Chapman C, Mortensen N, Lucassen A
  British Journal of General Practice 2004 Apr;54(501):267-71
• Molecular imaging of gene therapy for cancer
  K Shah, A Jacobs, X O Breakefield & R Weissleder
  Gene Therapy 2004 Aug, Vol. 11, No.15, Pg 1175-1187
• Cancer
  Nature Reviews Cancer 2004 Aug; 4; 573
• Genetic predisposition to colorectal cancer
  Albert de la Chapelle
  Nature Reviews Cancer2004 October; Vol 4; 769-780
• Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations
  Fabio Marroni et al
  European Journal of Human Genetics 2004 Nov, Vol 12, No. 11, Pg 899-906
• The human genome project and the discovery of genetic determinants of cancer susceptibility
  R. Taramelli and F. Acquati
  European Journal of Cancer 2004 Nov; Vol 40, Issue 17, Pg 2537-2543
• New Effort to Develop Molecular Tools for Early Cancer Detection Under Way
  Bridget M. Kuehn
  JAMA 16 February, 2005; Vol. 293 No. 7, pg 783-785
• Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer
  Graham Casey; Noralane M. Lindor; Nickolas Papadopoulos; Stephen N. Thibodeau; John Moskow; Scott Steelman; Carolyn H. Buzin; Steve S. Sommer; Christine E. Collins; Malinda Butz; Melyssa Aronson; Steven Gallinger; Melissa A. Barker; Joanne P. Young; Jeremy R. Jass; John L. Hopper; Anh Diep; Bharati Bapat; Michael Salem; Daniela Seminara; Robert Haile; for the Colon Cancer Family Registry
  JAMA 16 February 2005; 293;799-809
• Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands
  Sara González, Ignacio Blanco, c, Olga Campos, María Julià, José Reyes, Alfred Llompart, Elena Cabeza, Josep Ramon Germà, Antoni Obrador and Gabriel Capellá
  Cancer Genetics and Cytogenetics 1 April 2005, Vol 158, Issue 1 , Pg 70-74.
• BRCA1 and pancreatic cancer: pedigree findings and their causal relationships
  Henry T. Lynch, , , Carolyn A. Deters, Carrie L. Snyder, Jane F. Lynch, Pierre Villeneuve, Julie Silberstein, Holly Martin, Steven A. Narod and Randall E. Brand
  Cancer Genetics and Cytogenetics 15 April 2005, Vol 158, Issue 2, Pg 119-125
• Clinical response to morphine in cancer patients and genetic variation in candidate genes (16 August 2005)
  J R Ross, D Rutter, K Welsh, S P Joel, K Goller, A U Wells, R Du Bois and J Riley
  The Pharmacogenomics Journal (2005) 5, 324−336, 16 August